NANNI, CRISTINA
 Distribuzione geografica
Continente #
AS - Asia 3.171
NA - Nord America 3.101
EU - Europa 2.109
SA - Sud America 199
Continente sconosciuto - Info sul continente non disponibili 195
AF - Africa 171
OC - Oceania 3
Totale 8.949
Nazione #
US - Stati Uniti d'America 3.034
SG - Singapore 830
VN - Vietnam 815
CN - Cina 803
IT - Italia 459
GB - Regno Unito 369
DE - Germania 335
SE - Svezia 248
HK - Hong Kong 216
BR - Brasile 131
IN - India 131
FR - Francia 126
FI - Finlandia 120
RU - Federazione Russa 107
NL - Olanda 101
BD - Bangladesh 88
KR - Corea 80
IE - Irlanda 65
JP - Giappone 54
CI - Costa d'Avorio 44
TG - Togo 42
ZA - Sudafrica 37
CA - Canada 35
JO - Giordania 29
SC - Seychelles 29
UA - Ucraina 29
AR - Argentina 26
EE - Estonia 21
IQ - Iraq 21
AT - Austria 20
BG - Bulgaria 20
CH - Svizzera 18
PH - Filippine 17
ES - Italia 16
ID - Indonesia 16
BE - Belgio 15
MX - Messico 14
TR - Turchia 14
CL - Cile 10
NG - Nigeria 10
PL - Polonia 10
EC - Ecuador 9
TH - Thailandia 9
IR - Iran 7
PY - Paraguay 7
PK - Pakistan 6
TW - Taiwan 6
CO - Colombia 5
HR - Croazia 5
SK - Slovacchia (Repubblica Slovacca) 5
AL - Albania 4
CR - Costa Rica 4
IL - Israele 4
JM - Giamaica 4
SA - Arabia Saudita 4
UZ - Uzbekistan 4
VE - Venezuela 4
AU - Australia 3
LT - Lituania 3
MY - Malesia 3
OM - Oman 3
PE - Perù 3
RS - Serbia 3
BN - Brunei Darussalam 2
BS - Bahamas 2
CZ - Repubblica Ceca 2
GY - Guiana 2
HN - Honduras 2
KZ - Kazakistan 2
MA - Marocco 2
RO - Romania 2
SY - Repubblica araba siriana 2
AO - Angola 1
AZ - Azerbaigian 1
BB - Barbados 1
BO - Bolivia 1
BW - Botswana 1
BZ - Belize 1
DK - Danimarca 1
DZ - Algeria 1
EG - Egitto 1
GR - Grecia 1
GT - Guatemala 1
HU - Ungheria 1
KE - Kenya 1
LB - Libano 1
LK - Sri Lanka 1
MK - Macedonia 1
ML - Mali 1
MN - Mongolia 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
PR - Porto Rico 1
SI - Slovenia 1
SV - El Salvador 1
TN - Tunisia 1
UY - Uruguay 1
Totale 8.754
Città #
Singapore 573
Ashburn 389
Southend 308
Chandler 242
Hong Kong 205
San Jose 193
Fairfield 179
Hanoi 170
Hefei 167
Ho Chi Minh City 150
Santa Clara 122
Seattle 115
Munich 106
Beijing 105
Helsinki 99
Woodbridge 96
Houston 93
Dong Ket 89
Wilmington 87
Princeton 86
Council Bluffs 79
Cambridge 74
Bologna 72
Seoul 70
Boardman 68
Dublin 65
Dallas 62
Los Angeles 60
New York 52
Ann Arbor 50
Lauterbourg 49
Tokyo 46
Abidjan 44
Florence 42
Lomé 42
Westminster 33
Berlin 32
Frankfurt am Main 31
Nanjing 31
Amman 29
Haiphong 27
Da Nang 24
Buffalo 22
Milan 21
Redondo Beach 21
Turin 21
Guangzhou 20
Padova 20
Jinan 18
Rome 18
São Paulo 18
Bengaluru 17
Bremen 17
Tianjin 17
Jacksonville 16
Saint Petersburg 16
Sofia 16
Orem 15
San Francisco 15
Bern 14
San Diego 14
Shenyang 14
Amsterdam 13
Brussels 13
Changsha 13
Chicago 13
Hebei 13
Johannesburg 13
London 13
Brooklyn 12
Phoenix 12
Montreal 11
Nuremberg 11
Redmond 11
Toronto 11
Atlanta 10
Nanchang 10
Philadelphia 10
The Dalles 10
Abeokuta 9
Baghdad 9
Denver 9
Des Moines 9
Hangzhou 9
Jakarta 9
Redwood City 9
Shenzhen 9
Vienna 9
Falls Church 8
Jiaxing 8
Medford 8
Quận Bình Thạnh 8
Tongling 8
Wuhan 8
Biên Hòa 7
Boston 7
Haikou 7
Hyderabad 7
Hải Dương 7
Kuban 7
Totale 5.376
Nome #
18F-FDG PET/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease 359
PSMA PET for the Evaluation of Liver Metastases in Castration-Resistant Prostate Cancer Patients: A Multicenter Retrospective Study 322
A case of [68Ga]Ga-FAPI-46-avid and [18F]F-FDG-negative COVID-19 pneumonia sequelae 279
Standardization of 18F-FDG-PET/CT According to Deauville Criteria for Metabolic Complete Response Definition in Newly Diagnosed Multiple Myeloma 239
Radiologically defined lipid-poor adrenal adenomas: histopathological characteristics 231
Benign albeit glycolytic: MCT4 expression and lactate release in giant cell tumour of bone 226
18F-FACBC (anti1-amino-3-18F-fluorocyclobutane-1-carboxylic acid) versus 11C-choline PET/CT in prostate cancer relapse: results of a prospective trial 224
A Comparison of Different Staging Systems for Multiple Myeloma: Can the MRI Pattern Play a Prognostic Role? 212
Molecular imaging and targeted therapies in oncology: new concepts in treatment response assessment. a collection of cases. 203
Sclerosing Angiomatoid Nodular Transformation of the Adrenal Gland: A Case Report of a Novel Histopathological Entity 199
Diagnostic Innovations: Advances in imaging techniques for diagnosis and follow-up of multiple myeloma 196
The diagnostic dilemma of adrenal vascular tumors: analysis of 21 cases and systematic review of the literature 190
Potential Prognostic Role of 18F-FDG PET/CT in Invasive Epithelial Ovarian Cancer Relapse. A Preliminary Study 188
Compa rison of 18F-fluciclovine PET/CT with 11 C-Choline PET/CT for nodal staging in prostate cancer: a prospective study 188
High level of circulating cell-free tumor DNA at diagnosis correlates with disease spreading and defines multiple myeloma patients with poor prognosis 184
Cardiac FDG PET/CT to Assess the Culprit Lesion during Acute Infarction 175
Relation between thoracic aortic inflammation and features of plaque vulnerability in the coronary tree in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention. An FDG-positron emission tomography and optical coherence tomography study 170
Histological findings in patients with suspected mediastinal lymphoma relapse according to positive positron emission tomography scan during follow-up: a large retrospective analysis in 96 patients 169
Detection and localization of prostate cancer: correlation of (11)C-choline PET/CT with histopathologic step-section analysis 168
18F-FACBC PET/CT VS. 11C-CHOLINE FOR THE DETECTION OF PROSTATE CANCER RELAPSE AFTER RADICAL TREATMENT 167
[18F]-Fluciclovine PET/CT for preoperative nodal staging in high-risk primary prostate cancer: final results of a prospective trial 166
Report of the 6th International Workshop on PET in lymphoma 164
Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group 162
The role of 11C-choline PET imaging in the early detection of recurrence in surgically treated prostate cancer patients with very low PSA level <0.5 ng/mL. 161
POSITRON-EMISSION TOMOGRAPHY IN IMAGING AND STAGING PROSTATE CANCER 161
C–CHOLINE PET/CT IMAGING IS USEFUL FOR METASTATIC LYMPH NODES DETECTION IN NEWLY DIAGNOSED PROSTATE CANCER 157
C–CHOLINE PET/CT IMAGING IS USEFUL FOR METASTATIC LYMPH NODES DETECTION IN NEWLY DIAGNOSED PROSTATE CANCER 157
Role of 18F-FLT PET/CT in suspected recurrent or residual lymphoma: final results of a pilot prospective trial 157
Hodgkin lymphoma presenting with paraneoplastic myasthenia: a case report 150
Random survival forest to predict transplant-eligible newly diagnosed multiple myeloma outcome including FDG-PET radiomics: a combined analysis of two independent prospective European trials 150
The Dark Side of Activated Phosphoinositide 3-Kinase-δ Syndrome 2: A Story Rewritten through FDG-PET 149
TOMOGRAFIA AD EMISSIONE DI POSITRONI CON 11-C-COLINA INTEGRATO A UN SISTEMA TC (11-C-CHOLINE-PET/TC) NELLA DIAGNOSI DI NEOPLASIA PROSTATICA 148
Yttrium 90 Intra Arterial Radioembolization Therapy of Unresectable Intrahepatic Cholangiocarcinoma: 5 Year Experience at a Single Center 148
Psychometric Properties of the Italian Version of the Short-Form Supportive Care Needs Survey Questionnaire (SCNS-SF34-It): A Multicenter Validation Study 147
The role of 18F-FDG PET/CT in soft tissue sarcoma 136
The release of inflammatory mediators from acid-stimulated mesenchymal stromal cells favours tumour invasiveness and metastasis in osteosarcoma 134
In vivo treatment sensitivity testing with positron emission tomography/computed tomography after one cycle of chemotherapy for Hodgkin lymphoma. 132
Diagnostic role of 18F-FDG PET in gastric MALT lymphoma 131
Diagnostic imaging work-up for disease relapse after radical treatment for prostate cancer: how to differentiate local from systemic disease? The urologist point of view. 130
Therapy assessment in multiple myeloma with PET 129
USEFULNESS OF 11C-CHOLINE PET/CT IMAGING FOR DETECTION OF LYNPHONODE INVOLVENT IN NEWLY DIAGNOSED PROSTATE CANCER 118
The detection of disease relapse after radical treatment for prostate cancer: is anti-3-18F-FACBC PET/CT a promising option? 115
Glucose metabolism quantified by suvmax on baseline fdg-pet/ct predicts survival in newly diagnosed multiple myeloma patients: Combined harmonized analysis of two prospective phase iii trials 115
The dilemma of localizing disease relapse after radical treatment for prostate cancer: which is the value of the actual imaging techniques? 113
Impact of minimal residual disease standardised assessment by FDG-PET/CT in transplant-eligible patients with newly diagnosed multiple myeloma enrolled in the imaging sub-study of the FORTE trial 113
Methodological framework for radiomics applications in Hodgkin’s lymphoma 112
Functional imaging for therapeutic assessment and minimal residual disease detection in multiple myeloma 112
Spine Infections: The Role of Fluorodeoxyglucose Positron Emission Tomography (FDG PET) in the Context of the Actual Diagnosis Guideline 104
Skeletal survey in multiple myeloma: Role of imaging 103
Case Report: Pulmonary Actinomyces Infection Mimics Lung Cancer on [68Ga]Ga-FAPI PET/CT 101
Interest of pet imaging in multiple myeloma 101
Therapeutic potential of lorlatinib in ALK-mutated metastatic paraganglioma: Insights from clinical case report and literature review 94
Fluorodeoxyglucose-PET/Computed Tomography as a Predictor of Prognosis in Multiple Myeloma 85
Monoclonal and polyclonal circulating plasma cells (CPCs) are linked to disease spread in multiple myeloma 77
The Role of FDG-PET and Whole-Body MRI in High Grade Bone Sarcomas With Particular Focus on Osteosarcoma 71
The Role of Whole-Body MRI in Patients with Lymphoma: A Narrative Review 57
Learned Deep Radiomics for Survival Analysis with Attention 46
Mask-aware foundational-model embeddings for 18F-FDG-PET/CT prognosis in multiple myeloma 41
Automated Deauville Score computation from baseline [¹⁸F]FDG PET/CT predicts progression-free survival in multiple myeloma: a radiogenomic framework 13
Totale 8.949
Categoria #
all - tutte 25.338
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.338


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022761 0 32 43 60 80 27 18 56 26 55 231 133
2022/2023994 96 160 64 128 62 74 29 61 151 33 98 38
2023/2024305 41 38 17 22 31 55 19 21 7 18 27 9
2024/20251.444 51 128 123 113 150 86 166 76 55 126 92 278
2025/20263.548 379 292 300 244 348 183 325 148 704 265 206 154
2026/2027242 133 109 0 0 0 0 0 0 0 0 0 0
Totale 8.949